ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

NEXI NexImmune Inc

3.32
0.20 (6.41%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
NexImmune Inc NEXI 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.20 6.41% 3.32 13:00:06
개장가 저가 고가 종가 전일 종가
3.13 3.10 3.4899 3.32 3.12
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/03/202403:20BWKonzernergebnis zum 31. Dezember 2023 genehmigt, starke..
08/03/202402:33BWApprobation des résultats financiers du groupe au 31..
07/03/202415:31BWApprovati i risultati finanziari di Gruppo al 31 dicembre..
07/03/202415:30BWGroup Financial Results as of December 31st 2023 Approved,..
07/02/202406:42GLOBENexImmune Announces Closing of $3.67 Million Registered..
07/02/202406:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/02/202407:10EDGAR2Form 8-K - Current report
06/02/202406:34EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/02/202404:00GLOBENexImmune Announces $3.67 Million Registered Direct Offering..
03/02/202403:25EDGAR2Form 8-K - Current report
01/02/202423:17EDGAR2Form 8-K - Current report
20/01/202406:43EDGAR2Form 8-K - Current report
19/01/202406:43EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202306:01EDGAR2Form 8-K - Current report
02/12/202303:39EDGAR2Form 8-K - Current report
23/11/202307:40EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
23/11/202307:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202306:39EDGAR2Form 144 - Report of proposed sale of securities
21/11/202307:19EDGAR2Form DEF 14A - Other definitive proxy statements
21/11/202307:01EDGAR2Form 8-K/A - Current report: [Amend]
18/11/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/11/202306:17EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
10/11/202307:47EDGAR2Form PRE 14A - Other preliminary proxy statements
09/11/202323:35BWFinanzergebnisse der Gruppe zum 30. September 2023..
09/11/202322:52BWLes résultats financiers du groupe au 30 septembre 2023 ont..
09/11/202315:30BWApprovati I Risultati Finanziari Di Gruppo Al 30 Settembre..
03/11/202306:12EDGAR2Form 8-K - Current report
03/11/202305:33EDGAR2Form 8-K - Current report
24/10/202321:00GLOBENexImmune, Yale, and JDRF Extend Research Partnership for..
19/10/202321:00GLOBENexImmune Announces Presentations at The Society for..
19/10/202305:15EDGAR2Form 8-K - Current report
19/10/202300:30GLOBENexImmune Announces 1-for-25 Reverse Stock Split
26/09/202305:42EDGAR2Form DEF 14A - Other definitive proxy statements
16/09/202305:06EDGAR2Form 8-K - Current report
14/09/202306:14EDGAR2Form PRE 14A - Other preliminary proxy statements
09/09/202308:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/09/202306:11EDGAR2Form 8-K - Current report
01/09/202305:45GLOBENexImmune Announces Workforce Reduction to Enable Continued..
11/08/202305:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:06EDGAR2Form 8-K - Current report
11/08/202305:01GLOBENexImmune Reports Second Quarter 2023 Financial Results and..
02/08/202307:21BWFinanzergebnisse der Gruppe zum 30. Juni 2023 bestätigen..
01/08/202314:23BWGroup Financial Results as of June 30th 2023, Approved Solid..
08/07/202305:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/07/202305:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/07/202305:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/07/202305:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/06/202321:01GLOBENexImmune Presents Initial Positive Data from the NEXI-001..
23/05/202305:01GLOBENexImmune Announces Poster Presentation at the 2023 FOCIS..
16/05/202305:01GLOBENexImmune Reports First Quarter 2023 Financial Results and..

최근 히스토리

Delayed Upgrade Clock